Stocks and Investing
by (remove) : Marc Frahm
RSS • JSON • XML • CSV
Stocks and Investing
by (remove) : Marc Frahm
RSS • JSON • XML • CSV

Marc Frahm Maintained (TBPH) at Hold with Decreased Target to $9 on, Aug 6th, 2024


Published on 2024-10-28 13:14:52 - WOPRAI, Marc Frahm
  Print publication without navigation


Marc Frahm of TD Cowen, Maintained "Theravance Biopharma, Inc." (TBPH) at Hold with Decreased Target from $10 to $9 on, Aug 6th, 2024.

Marc has made no other calls on TBPH in the last 4 months.



There is 1 other peer that has a rating on TBPH. Out of the 1 peers that are also analyzing TBPH, 0 agree with Marc's Rating of Hold.



This is the rating of the analyst that currently disagrees with Marc

  • Julian Harrison of "BTIG" Initiated at Strong Buy and Held Target at $21 on, Friday, April 12th, 2024
Contributing Sources